Santeri A Pakola (S Pakola)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Pluripotent Stem Cells

Prognostic Factors

Top Venues

Cancer gene therapy

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Santeri A Pakola, Katriina J Peltola, James H A Clubb, Elise Jirovec, Lyna Haybout, Tatiana Viktorovna Kudling, Tuomo Alanko, Riitta Korpisaari, Susanna M Juteau, Marjut Laukka, Jorma Sormunen, Jukka Kemppainen, Annabrita Hemmes, Teijo Pellinen, Mirte van der Heijden, Dafne C A Quixabeira, Claudia Kistler, Suvi Sorsa, Riikka Havunen, Joao M Santos, Victor Cervera-Carrascon, Akseli E Hemminki
Safety, Efficacy, and Biological Data of T-Cell-Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Santeri A Pakola, Katriina J Peltola, James H A Clubb, Elise Jirovec, Lyna Haybout, Tatiana Viktorovna Kudling, Tuomo Alanko, Riitta Korpisaari, Susanna M Juteau, Marjut Laukka, Jorma Sormunen, Jukka Kemppainen, Annabrita Hemmes, Teijo Pellinen, Mirte van der Heijden, Dafne C A Quixabeira, Claudia Kistler, Suvi Sorsa, Riikka Havunen, Joao M Santos, Victor Cervera-Carrascon, Akseli E Hemminki
Safety, efficacy, and biological data of T cell-enabling oncolytic adenovirus TILT-123 in advanced solid cancers from the TUNIMO monotherapy phase I trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Dafne C A Quixabeira, E Jirovec, Santeri A Pakola, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine. Cancer gene therapy (2023)
Dafne C A Quixabeira, Santeri A Pakola, E Jirovec, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Erja Kerkelä, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer. Cancer gene therapy (2023)